Inhibition of thromboxane synthase induces lung cancer cell death via increasing the nuclear p27

Experimental Cell Research

Volumn 315, Issue 17, 2009, Pages 2974-2981

  Leung, Kin Chung ^a   Hsin, Michael K Y ^a   Chan, Joey S Y ^a   Yip, Johnson H Y ^a   Li, Mingyue ^a   Leung, Billy C S ^a   Mok, Tony S K ^a   Warner, Timothy D ^b   Underwood, Malcolm J ^a   Chen, George G ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^b QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Apoptosis; Cell death; Lung cancer; p27; Thromboxane synthase

Indexed keywords

PROTEIN P27; SMALL INTERFERING RNA; THROMBOXANE SYNTHASE;

APOPTOSIS; ARTICLE; CANCER TISSUE; CELL DEATH; CELL LEVEL; CELL NUCLEUS; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME INHIBITION; ENZYME SYNTHESIS; HUMAN; HUMAN CELL; HUMAN TISSUE; LUNG ADENOCARCINOMA; LUNG CANCER; LUNG CARCINOGENESIS; LUNG NON SMALL CELL CANCER; LUNG SQUAMOUS CELL CARCINOMA; PRIORITY JOURNAL; RNA INTERFERENCE; WESTERN BLOTTING;

EID: 70349439120     PISSN: 00144827     EISSN: 10902422     Source Type: Journal    
DOI: 10.1016/j.yexcr.2009.06.025     Document Type: Article

References (35)

1. Moussa O., Riker J.M., Klein J., Fraig M., Halushka P.V., and Watson D.K. Inhibition of thromboxane synthase activity modulates bladder cancer cell responses to chemotherapeutic agents. Oncogene 27 (2008) 55-62
2. Watkins G., Douglas-Jones A., Mansel R.E., and Jiang W.G. Expression of thromboxane synthase, TBXAS1 and the thromboxane A2 receptor, TBXA2R, in human breast cancer. Int. Semin. Surg. Oncol. 2 (2005) 23
3. Sakai H., Suzuki T., Takahashi Y., Ukai M., Tauchi K., Fujii T., Horikawa N., Minamimura T., Tabuchi Y., Morii M., Tsukada K., and Takeguchi N. Upregulation of thromboxane synthase in human colorectal carcinoma and the cancer cell proliferation by thromboxane A2. FEBS Lett. 580 (2006) 3368-3374
4. Kürzel F., Hagel Ch., Zapf S., Meissner H., Westphal M., and Giese A. Cyclo-oxygenase inhibitors and thromboxane synthase inhibitors differentially regulate migration arrest, growth inhibition and apoptosis in human glioma cells. Acta Neurochir. (Wien) 144 (2002) 71-87
5. Onguru O., Scheithauer B.W., Kovacs K., Vidal S., Jin L., Zhang S., Ruebel K.H., and Lloyd R.V. Analysis of Cox-2 and thromboxane synthase expression in pituitary adenomas and carcinomas. Endocr. Pathol. 15 (2004) 17-27
6. Nie D., Che M., Zacharek A., Qiao Y., Li L., Li X., Lamberti M., Tang K., Cai Y., Guo Y., Grignon D., and Honn K.V. Differential expression of thromboxane synthase in prostate carcinoma: role in tumor cell motility. Am. J. Pathol. 164 (2004) 429-439
7. Kajita S., Ruebel K.H., Casey M.B., Nakamura N., and Lloyd R.V. Role of COX-2, thromboxane A2 synthase, and prostaglandin I2 synthase in papillary thyroid carcinoma growth. Mod. Pathol. 18 (2005) 221-227
8. Chen G.G., Lee T.W., Yip J.H., Xu H., Lee I.K., Mok T.S., Warner T.D., and Yim A.P. Increased thromboxane B(2) levels are associated with lipid peroxidation and Bcl-2 expression in human lung carcinoma. Cancer Lett. 234 (2006) 193-198
9. Fujimura M., Kasahara K., Shirasaki H., Heki U., Iwasa K., Ueda A., and Matsuda T. Up-regulation of ICH-1L protein by thromboxane A2 antagonists enhances cisplatin-induced apoptosis in non-small-cell lung-cancer cell lines. J. Cancer Res. Clin. Oncol. 125 (1999) 389-394
10. Bando T., Fujimura M., Kasahara K., and Matsuda T. Role of thromboxane receptor on the intracellular accumulation of cis-diamminedichloroplatinum(II) in non-small-cell but not in small-cell lung cancer cell lines. Anticancer Res. 18 (1998) 1079-1084
11. Fero M.L., Rivkin M., Tasch M., Porter P., Carow C.E., Firpo E., Polyak K., Tsai L.H., Broudy V., Perlmutter R.M., Kaushansky K., and Roberts J.M. A syndrome of multiorgan hyperplasia with features of gigantism, tumorigenesis, and female sterility in p27(Kip1)-deficient mice. Cell 85 (1996) 733-744
12. Chu I.M., Hengst L., and Slingerland J.M. The Cdk inhibitor p27 in human cancer: prognostic potential and relevance to anticancer therapy. Nat. Rev. Cancer 8 (2008) 253-267
13. Osoegawa A., Yoshino I., Kometani T., Yamaguchi M., Kameyama T., Yohena T., and Maehara Y. Overexpression of Jun activation domain-binding protein 1 in nonsmall cell lung cancer and its significance in p27 expression and clinical features. Cancer 107 (2006) 154-161
14. Pateras I.S., Apostolopoulou K., Koutsami M., Evangelou K., Tsantoulis P., Liloglou T., Nikolaidis G., Sigala F., Kittas C., Field J.K., Kotsinas A., and Gorgoulis V.G. Downregulation of the KIP family members p27(KIP1) and p57(KIP2) by SKP2 and the role of methylation in p57(KIP2) inactivation in nonsmall cell lung cancer. Int. J. Cancer 119 (2006) 2546-2556
15. Hung W.C., Chang H.C., Pan M.R., Lee T.H., and Chuang L.Y. Induction of p27(KIP1) as a mechanism underlying NS398-induced growth inhibition in human lung cancer cells. Mol. Pharmacol. 58 (2000) 1398-1403
16. Park K.H., Seol J.Y., Yoo C.G., Kim Y.W., Han S.K., Lee E.H., Kim C.M., Shim Y.S., and Lee C.T. Adenovirus expressing p27(Kip1) induces growth arrest of lung cancer cell lines and suppresses the growth of established lung cancer xenografts. Lung Cancer 31 (2001) 149-155
17. Katayose Y., Kim M., Rakkar A.N., Li Z., Cowan K.H., and Seth P. Promoting apoptosis: a novel activity associated with the cyclin-dependent kinase inhibitor p27. Cancer Res. 57 (1997) 5441-5445
18. Fujieda S., Inuzuka M., Tanaka N., Sunaga H., Fan G.K., Ito T., Sugimoto C., Tsuzuki H., and Saito H. Expression of p27 is associated with Bax expression and spontaneous apoptosis in oral and oropharyngeal carcinoma. Int. J. Cancer 84 (1999) 315-320
19. Kim W.H., Ghil K.C., Lee J.H., Yeo S.H., Chun Y.J., Choi K.H., Kim D.K., and Kim M.Y. Involvement of p27(kip1) in ceramide-mediated apoptosis in HL-60 cells. Cancer Lett. 151 (2000) 39-48
20. Wang Q., Zhang M., Fang H., Nie X., Gao L., Liu Y., and Xie Y. Effect of adenovirus-mediated p27 gene expression on the proliferation and apoptosis of HL-60 and Raji cell lines. Hematol. J. 5 (2004) 519-523
21. Zhang R., Banik N.L., and Ray S.K. Combination of all-trans retinoic acid and interferon-gamma upregulated p27(kip1) and down regulated CDK2 to cause cell cycle arrest leading to differentiation and apoptosis in human glioblastoma LN18 (PTEN-proficient) and U87MG (PTEN-deficient) cells. Cancer Chemother. Pharmacol. 62 (2008) 407-416
22. Wang P., Ma Q., Luo J., Liu B., Tan F., Zhang Z., and Chen Z. Nkx3.1 and p27(KIP1) cooperate in proliferation inhibition and apoptosis induction in human androgen-independent prostate cancer cells. Cancer Invest. 27 (2009) 369-375
23. Li M., Lee T.W., Yim A.P., Mok T.S., and Chen G.G. Apoptosis induced by troglitazone is both peroxisome proliferator-activated receptor-gamma- and ERK-dependent in human non-small lung cancer cells. J. Cell. Physiol. 209 (2006) 428-438
24. Song G., Chen G.G., Chau K.J., Miao J., and Lai B.S. Bid exhibits Sphase checkpoint activation and plays a pro-apoptotic role in response to etoposide-induced DNA damage in human hepatoma cells. Apoptosis 13 (2008) 693-701
25. Jones C.M., Hall E.R., Hester J.P., and Wu K.K. Arachidonic acid metabolites produced by platelet-depleted human blood monocytes: a possible role in thrombogenesis. Am. J. Hematol. 31 (1989) 145-152
26. Golin J., Ambudkar S.V., Gottesman M.M., Habib A.D., Sczepanski J., Ziccardi W., and May L. Studies with novel Pdr5p substrates demonstrate a strong size dependence for xenobiotic efflux. J. Biol. Chem. 278 (2003) 5963-5969
27. Grabowski P., Schrader J., Wagner J., Hörsch D., Arnold R., Arnold C.N., Georgieva I., Stein H., Zeitz M., Daniel P.T., and Sturm I. Loss of nuclear p27 expression and its prognostic role in relation to cyclin E and p53 mutation in gastroenteropancreatic neuroendocrine tumors. Clin. Cancer Res. 14 (2008) 7378-7384
28. Ogino S., Kawasaki T., Kirkner G.J., Yamaji T., Loda M., and Fuchs C.S. Loss of nuclear p27 (CDKN1B/KIP1) in colorectal cancer is correlated with microsatellite instability and CIMP. Mod. Pathol. 20 (2007) 15-22
29. Kim J., Jonasch E., Alexander A., Short J.D., Cai S., Wen S., Tsavachidou D., Tamboli P., Czerniak B.A., Do K.A., Wu K.J., Marlow L.A., Wood C.G., Copland J.A., and Walker C.L. Cytoplasmic sequestration of p27 via AKT phosphorylation in renal cell carcinoma. Clin. Cancer Res. 15 (2009) 81-90
30. Besson A., Assoian R.K., and Roberts J.M. Regulation of the cytoskeleton: an oncogenic function for CDK inhibitors?. Nat. Rev. Cancer 4 (2004) 948-955
31. Besson A., Hwang H.C., Cicero S., Donovan S.L., Gurian-West M., Johnson D., Clurman B.E., Dyer M.A., and Roberts J.M. Discovery of an oncogenic activity in p27Kip1 that causes stem cell expansion and a multiple tumor phenotype. Genes Dev. 21 (2007) 1731-1746
32. Wei J., Yan W., Li X., Chang W.C., and Tai H.H. Activation of thromboxane receptor alpha induces expression of cyclooxygenase-2 through multiple signaling pathways in A549 human lung adenocarcinoma cells. Biochem. Pharmacol. 74 (2007) 787-800
33. Schauff A.K., Kim E.L., Leppert J., Nadrowitz R., Wuestenberg R., Brockmann M.A., and Giese A. Inhibition of invasion-associated thromboxane synthase sensitizes experimental gliomas to gamma-radiation. J. Neuro-oncol. 91 (2009) 241-249
34. Haider A., Lee I., Grabarek J., Darzynkiewicz Z., and Ferreri N.R. Dual functionality of cyclooxygenase-2 as a regulator of tumor necrosis factor-mediated G1 shortening and nitric oxide-mediated inhibition of vascular smooth muscle cell proliferation. Circulation 108 (2003) 1015-1021
35. Denicourt C., Saenz C.C., Datnow B., Cui X.S., and Dowdy S.F. Relocalized p27Kip1 tumor suppressor functions as a cytoplasmic metastatic oncogene in melanoma. Cancer Res. 67 (2007) 9238-9243